Embolx Announces FDA Clearance of Next-generation Sniper Balloon Occlusion Microcatheter
from Diagnostic and Interventional Cardiology
Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration for its next-generation family of Sniper Balloon Occlusion Microcatheters for pressure-directed arterial embolization therapy. Now commercially available in the United States, the next-generation family of Sniper devices offers physicians enhanced performance features to improve access and allow easy navigation through small complex vascular structures.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063